Effect of Armodafinil on Simulated Driving, Electroencephalogram and Cognitive Performance in Sleep Deprived Healthy Subjects

Next Previous
Trial Profile

Effect of Armodafinil on Simulated Driving, Electroencephalogram and Cognitive Performance in Sleep Deprived Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Dec 2017

At a glance

  • Drugs Armodafinil (Primary)
  • Indications Eating disorders; Fatigue; Hypersomnia
  • Focus Pharmacokinetics; Therapeutic Use

    • Most Recent Events

    • 30 Nov 2017 Status changed from recruiting to completed.
    • 23 May 2017 Planned End Date changed from 1 Jul 2017 to 31 Dec 2017.
    • 23 May 2017 Planned primary completion date changed from 1 Jul 2017 to 31 Dec 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top